CytoDyn Inc
For the period ended May 31, 2024. Filed Aug 15, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Aug 15, 2024
CYDYStored price and day change unavailable
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
| CONTENTS · PAGE | ||
|---|---|---|
| REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (Marcum LLP PCAOB ID 688) | | 49 |
| REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (Macias Gini & O’Connell LLP PCAOB ID 324) | | 51 |
| CONSOLIDATED BALANCE SHEETS AS OF MAY 31, 2024 AND 2023 | | 53 |
| CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE FISCAL YEARS ENDED MAY 31, 2024 AND 2023 | | 54 |
| CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT FOR THE FISCAL YEARS ENDED MAY 31, 2024 AND 2023 | | 55 |
| CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE FISCAL YEARS ENDED MAY 31, 2024 AND 2023 | | 57 |
| NOTES TO CONSOLIDATED FINANCIAL STATEMENTS | | 58 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.